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INTRODUCTION
Neural crest cells are an essential, multipotent 
cell population in the vertebrate embryo. During de-
velopment, these cells must undergo coordinated 
induction, specification, and epithelial—mesenchy-
mal transition (EMT) events to migrate and ultimately 
form a myriad of tissues, including craniofacial struc-
tures, components of the peripheral nervous system, 
as well as many other derivatives (Gandhi and Bron-
ner, 2018). The transcriptional control of these events 
has been dissected and mapped into modules of a 
feed-forward gene regulatory network (GRN), which 
help explain the detailed sequence of events involved 
in neural crest development (Martik and Bronner, 
2017; Simoes-Costa and Bronner, 2015; Williams 
et al., 2019). Recently, there has been growing ap-
preciation for the role that post-transcriptional regu-
lation plays in the establishment, maintenance, and 
regulation of neural crest formation (Bhattacharya et 
al., 2018; Sanchez-Vasquez et al., 2019; Ward et al., 
2018; Weiner, 2018). However, to date, much of the 
work on post-transcriptional regulation in neural crest 
has been focused on the role of microRNAs.
Given that RNA-binding proteins (RBPs) play an 
essential role in post-transcriptional regulatory pro-
cesses (Dassi, 2017), we sought to identify RBPs 
with early roles in neural crest development. To this 
end, we analyzed available RNA-sequencing data-
sets (Williams et al., 2019) from specification-stage 
avian embryos to identify enriched RBP candidates. 
Using this approach, we identified Elavl1, which en-
codes the RBP HuR, as an enriched transcript in 
newly formed neural crest cells. 
HuR is a nucleocytoplasmic shuttling protein from 
the ELAV (embryonic lethal abnormal vision) family 
of RBPs, which have conserved roles in neural de-
velopment (Ma et al., 1996; Yao et al., 1993). It is a 
well-established stabilizer of mRNA, a function often 
mediated via its association with the 3’-untranslated 
region (3’-UTR) of its mRNA targets (Abdelmohsen 
and Gorospe, 2010). Interestingly, HuR has been 
linked to Wnt signaling regulation (Kim et al., 2015; 
Palomo-Irigoyen et al., 2020), craniofacial develop-
ment (Katsanou et al., 2009), as well as cancer cell 
EMT (Wang et al., 2013); as these processes are also 
associated with neural crest development, we sought 
to determine the function of HuR in the neural crest.
Here, we describe a role for HuR in specification 
of cranial neural crest cells. We found that perturba-
tion of HuR led to premature neural crest delamina-
tion, as well as significant reduction in the expres-
sion of genes regulating the neural crest specification 
Neural crest development is transcriptionally controlled via sequential activation of gene regulatory 
networks (GRNs). Recent evidence increasingly implicates a role for post-transcriptional regulation in 
modulating the output of these regulatory circuits. Using RNA-sequencing data from avian embryos 
to identify potential post-transcriptional regulators, we observed enrichment during early neural 
crest development of Elavl1, which encodes for the RNA-binding protein HuR. Immunohistochemical 
analyses revealed expression of HuR following establishment of the neural plate border. Perturbation 
of HuR resulted in premature neural crest delamination from the neural tube as well as significant 
reduction in transcripts associated with the neural crest specification GRN (Axud1 and FoxD3), 
phenotypes also observed with downregulation of the canonical Wnt inhibitor Draxin. RNA pulldown 
further shows that Draxin is a specific target of HuR. Importantly, overexpression of exogenous Draxin 
was able to rescue the cranial neural crest specification defects observed with HuR knockdown. 
Thus, HuR plays a critical a role in the maintenance of cranial neural crest specification, at least 
partially via Draxin mRNA stabilization. Together, these data highlight an important intersection of 
post-transcriptional regulation with modulation of the neural crest specification GRN.
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2GRN. We show that these effects were mediated by 
loss of Draxin, a direct mRNA target of HuR. Our data 
demonstrate a critical role for HuR, and RBP-mediat-
ed post-transcriptional control, in the regulation of a 
critical neural crest specification module.
RESULTS
The RNA-binding protein HuR is expressed 
in cranial neural crest
Cranial neural crest cells are indispensable for 
proper craniofacial development (van Limborgh et 
al., 1983; Vega-Lopez et al., 2018). By analyzing 
RNA-sequencing datasets  from avian embryos at 
the 5-6 somite (Williams et al., 2019) corresponding 
to the time at which neural crest specification is com-
plete, we identified enrichment of Elavl1 transcripts 
which encodes the RNA-binding protein HuR. Giv-
en that HuR knockout mice often display defects in 
craniofacial structures (Katsanou et al., 2009), we 
hypothesized a potential role for HuR during cranial 
neural crest development. To this end, we first ex-
amined the expression pattern of HuR in the devel-
oping chick embryo. Early in neurulation, when the 
neural plate border (NPB) is established within the 
rising neural folds, HuR expression was detected in 
the anterior open neural tube and closing neural folds 
surrounding the anterior neuropore but absent from 
Pax7-expressing NPB cells (Fig. 1A). As the neural 
tube closed, when neural crest specification is com-
plete, HuR expression became enriched throughout 
the neural tube and overlapped with Pax7 expression 
in premigratory cranial neural crest cells (Fig. 1B-C). 
Following cranial neural crest epithelial—mesenchy-
mal transition (EMT), HuR remained expressed in 
the migratory neural crest cells, as well as through-
out the brain and neural tube (Fig. 1D). Thus, HuR 
is expressed in specified, premigratory cranial neural 
crest cells following establishment of the NPB and is 
retained during the onset of EMT and in early migrat-
ing cranial neural crest cells.
HuR downregulation alters cranial neural 
crest specification and delamination
To determine what, if any, role HuR has in cranial 
neural crest development, we perturbed HuR function 
in the early embryo using a translation-blocking anti-
sense morpholino oligo (MO). We co-electroporated 
a DNA construct driving expression of a fluorescent 
protein with control or HuR MOs bilaterally into gas-
trula stage chick embryos, and analyzed neural crest 
specification using quantitative fluorescent hybridiza-
tion chain reaction (HCR) to measure neural crest 
specifier expression at HH9. Given HuR’s associa-
tion with Wnt signaling (Kim et al., 2015) and the es-
sential roles Wnt signaling plays during early neural 
crest development (Milet and Monsoro-Burq, 2012; 
Rabadán et al., 2016; Simoes-Costa and Bronner, 
2015; Steventon and Mayor, 2012; Wu et al., 2003; 
Yanfeng et al., 2003), we focused on the Wnt effector 
Axud1, its target and neural crest specifier FoxD3, 
and the Wnt antagonist Draxin (Hutchins and Bron-
ner, 2018, 2019; Simoes-Costa et al., 2015). Follow-
ing HuR knockdown (Figure 2—Supplement 1; 61.4 
± 0.9% of the control side, P < 0.001, paired t-test, n 
= 5 embryos, 15 sections), we observed significant 
reduction in the levels of Axud1 (Fig. 2A; 76.9 ± 4.0% 
of the control side, P = 0.0295, paired t-test, n = 7 
embryos), FoxD3 (Fig. 2B; 61.3 ± 5.5% of the control 
side, P = 0.012, paired t-test, n = 10 embryos), and 
Draxin (Fig. 2C; 66.5 ± 2.5% of the control side, P = 
0.008, paired t-test, n = 4 embryos) transcripts com-
pared to contralateral control sides (Fig. 2D). Thus, 
HuR knockdown abrogated cranial neural crest spec-
ification, as indicated by loss of the early neural crest 
specifier FoxD3 and its activator Axud1, as well as 
the EMT regulator Draxin.
We also examined Pax7 to assess if HuR knock-
down had an effect on maintenance of the NPB. In-
terestingly, the total number of Pax7+ cells was un-
affected with HuR knockdown (101.3 ± 4.5% of the 
control side, P = 0.84, paired t-test, n = 4 embryos, 
11 sections); however we found significant increase 
in the number of Pax7+ cells that delaminated from 
the neural tube (139.4 ± 8.4% of the control side, P 
= 0.009, paired t-test), and concomitant decrease in 
the number of Pax7+ cells retained within the dor-
sal neural tube (66.0 ± 5.3% of the control side, P 
< 0.001, paired t-test) (Fig. 2E-F). Taken together, 
these data suggest that HuR is required during early 
cranial neural crest development to regulate specifi-
cation and prevent premature delamination.
Draxin is a HuR target during cranial neural 
crest specification
We have previously shown that Draxin knock-
down induces premature cranial neural crest delam-
ination and loss of neural crest specifier expression 
(Hutchins and Bronner, 2018), as we observed for HuR 
knockdown (Fig. 2). Given that HuR has been shown 
to stabilize mRNA targets and that HuR knockdown 
resulted in loss of Draxin (Fig. 2), we hypothesized 
that Draxin may be a HuR target during cranial neural 
crest specification.  Consistent with this, we identified 
several putative HuR binding sites within the Drax-
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3Figure 1. The RNA-binding protein HuR is expressed in cranial neural crest. 
(A-D) Representative epifluorescence images of wild type HH8- (A), HH9 (B-C), and HH9+ (D) chick embryos, in whole mount (A, B, D) and 
cross-section (C), immunostained for HuR (cyan) and Pax7 (magenta). Dotted white line (B) indicates level of cross-section (C). NF, neural 
folds; NT, neural tube; pNC, premigratory neural crest; mNC, migratory neural crest. Scale bar, 50 μm.
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4Figure 2. HuR knockdown alters cranial neural crest specification and delamination. 
(A-C) Representative confocal maximum intensity projection micrographs of HCR processed embryos for Axud1 (A), FoxD3 (B), or Draxin 
(C) transcripts in whole mount embryos bilaterally co-electroporated with a fluorescent electroporation control construct (insets) and control 
morpholino (left) or HuR morpholino (right). Images in (A) and (B) are from same embryo. Dotted white line indicates midline. Insets show 
fluorescent electroporation control. MO, morpholino. Scale bar, 50 μm.
(D) Relative fluorescence intensity of Axud1, FoxD3, and Draxin for HuR knockdown compared to control sides of individual embryos, 
calculated as ratio of HuR morpholino versus control morpholino integrated density. *, P < 0.05, paired t-test.
(E) Representative confocal maximum intensity projection micrographs of cross-sectioned embryo bilaterally co-electroporated with a 
fluorescent electroporation control construct (H2B-RFP) and control morpholino (left) or HuR morpholino (right), immunostained for Pax7 
(yellow). Nuclei were stained with DAPI (blue). Dotted white line indicates midline. Dashed white lines indicate limit of dorsal neural tube. 
Arrows indicate “neural tube” Pax7 cells. Asterisks indicate “delaminated” Pax7 cells. Scale bar, 20 μm.
(F) Quantification of the ratio of Pax7+ cells on HuR morpholino (right) versus control morpholino (left) sides of cross-sections. Data are from 
individual sections; sections from same embryo are displayed in same color (n = 4 embryos, 11 sections) *, P < 0.01, paired t-test.
See also Figure 2—Supplement 1.
Figure 3. HuR associates with Draxin mRNA during cranial neural crest specification. 
(A) Experimental design of RNA-binding protein/RNA co-immunoprecipitation (RIP) to test RNA association with HuR in vivo for neural crest 
targets. Lysates generated from HH9 heads were incubated with antibody-coated beads for HuR or a non-specific IgG to co-immunoprecipitate 
protein with bound RNAs. In qRT-PCR, specifically bound RNAs would be more abundant and reach threshold before RNAs that were 
nonspecific, and therefore would have smaller CT values. CT, threshold cycle.
(B) Real-time qRT-PCR of RNAs eluted from RIP. ns, non-significant, P = 0.89, one-way ANOVA with Tukey’s post hoc test. *, P < 0.001, one-
way ANOVA with Tukey’s post hoc test. ΔΔCT, Average Control IgG ΔCT − HuR ΔCT, where ΔCT = Input CT − IP CT. Error bars, SEM.
See also Figure 3—Supplement 1.
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5in 3’-UTR (Figure 3—Supplement 1), To test this 
possibility, we performed an RNA immunoprecipita-
tion (RIP) followed by quantitative reverse transcrip-
tion-PCR (qRT-PCR) to pull down endogenous HuR 
ribonucleoprotein (RNP) complexes. To this end, 
we incubated lysate generated from wild type HH9 
embryonic heads with magnetic beads coated with 
either HuR antibody or a rabbit IgG non-specific con-
trol antibody, then eluted bound RNA and performed 
qRT-PCR. We expected that RNAs specifically bound 
by HuR would be significantly enriched compared to 
non-specifically associated RNAs; this translates to a 
greater ΔΔCT value for a target versus a non-target 
when HuR ΔCT values (IP fraction normalized to In-
put) are subtracted from control IgG ΔCT values (Fig. 
3A). Given that we observed no change in the total 
number of Pax7+ cells with HuR knockdown (Fig. 2), 
we classified Pax7 as a non-target, and compared 
Draxin and FoxD3 ΔΔCT values to Pax7 ΔΔCT. We 
found that Pax7 and FoxD3 ΔΔCT values were neg-
ative (i.e. less enriched than the non-specific control 
IP), and not significantly different from each other (P 
= 0.89, one-way ANOVA with Tukey’s post hoc test); 
however, Draxin ΔΔCT was positive (i.e. enriched 
over the non-specific control IP), and significantly 
different from Pax7 and FoxD3 ΔΔCT values (P < 
0.001, one-way ANOVA with Tukey’s post hoc test) 
(Fig. 3B). Thus, these data suggest that Draxin is a 
specific target of HuR, and defects in FoxD3 may be 
indirect.
HuR maintains cranial neural crest 
specification via Draxin mRNA stabilization
Our RIP data suggest that HuR specifically as-
sociates with Draxin mRNA, but not FoxD3. To de-
termine if defects in cranial neural crest specification 
with HuR knockdown were indirect, we examined 
Figure 4. HuR maintains cranial neural crest specification through Draxin. 
(A) Representative confocal maximum intensity projection micrographs of HCR processed embryos for Axud1 (A) or FoxD3 (A’) transcripts 
in whole mount embryos bilaterally co-electroporated with a fluorescent electroporation control construct (A”) and control morpholino (left) or 
Draxin morpholino (right). Dotted white line indicates midline. MO, morpholino. Scale bar, 50 μm.
(B) Relative fluorescence intensity of Axud1 and FoxD3 for Draxin knockdown compared to control sides of individual embryos, calculated as 
ratio of Draxin morpholino versus control morpholino integrated density. *, P = 0.002, paired t-test.
(C) Representative confocal maximum intensity projection micrographs of HCR processed embryo for FoxD3 (C) and Draxin (C’) transcripts 
in whole mount embryo bilaterally electroporated with control morpholino (left) or HuR morpholino + Draxin overexpression construct (right). 
Dotted white line indicates midline. MO, morpholino; OE, overexpression. Scale bar, 50 μm.
(D) Relative fluorescence intensity of FoxD3 for HuR morpholino + Draxin overexpression compared to control sides of individual embryos, 
calculated as ratio of HuR morpholino + Draxin overexpression versus control morpholino integrated density. HuR morpholino data (gray) 
were originally presented in Fig. 2 and displayed here for comparison. ns, non-significant, P = 0.14, paired t-test. *, P = 0.02, unpaired one-
tailed t-test.
See also Figure 4—Supplement 1.
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6FoxD3 and Axud1 expression in Draxin knockdown 
embryos. As with HuR MO, we electroporated control 
and Draxin MO (Hutchins and Bronner, 2018, 2019) 
bilaterally, and performed HCR at HH9. We identified 
significant reductions in both Axud1 (48.8 ± 5.1% of 
the control side, P = 0.002, paired t-test) and FoxD3 
(26.8 ± 3.2% of the control side, P < 0.001, paired 
t-test) with Draxin knockdown (Fig. 4A-B). To deter-
mine if dysregulation of neural crest specification with 
HuR knockdown was solely due to loss of Draxin, we 
asked whether Draxin upregulation was sufficient 
to rescue the HuR MO phenotype. To this end, we 
co-electroporated HuR MO with a Draxin overexpres-
sion construct (Hutchins and Bronner, 2018, 2019), 
and assessed neural crest specification with HCR 
(Fig. 4C). Indeed, exogenous Draxin was sufficient 
to significantly restore FoxD3 expression from HuR 
knockdown (84.5 ± 9.6% of the control side, P < 0.02, 
unpaired one-tailed t-test) to near-control expression 
levels (P = 0.14, paired t-test) (Fig. 4D).
We also examined the effects of HuR knockdown 
on cranial neural crest EMT. Consistent with our pre-
vious results with Draxin knockdown (Hutchins and 
Bronner, 2018, 2019), HuR knockdown similarly im-
peded cranial neural crest emigration (Figure 4—
Supplement 1; 63.6 ± 4.1% of the control side, P < 
0.001, paired t-test). Given that HuR expression per-
sists during cranial neural crest EMT (Fig. 1) when its 
target Draxin is downregulated, HuR may well bind 
other specific targets necessary for and/or following 
EMT. Taken together, these data suggest that HuR 
is required for Draxin mRNA stabilization to maintain 
cranial neural crest specification and likely binds sep-
arate targets to facilitate EMT.
DISCUSSION
Our understanding of neural crest development 
has been greatly increased through the identification 
of key transcriptional circuits that control its develop-
mental progression. Recent studies suggest a critical 
role for post-transcriptional regulation in the refine-
ment of the expression outputs of these GRNs. Here, 
we identified and characterized HuR, an RBP essen-
tial for the maintenance of cranial neural crest specifi-
cation via its regulation of the Wnt antagonist Draxin.
Given that HuR associated endogenously with 
Draxin mRNA (Fig. 3), and its knockdown resulted in 
reduced Draxin levels (Fig. 2) and specification de-
fects that were rescued with exogenous expression 
of the Draxin coding sequence (Fig. 4), we postulate 
that HuR likely promotes Draxin mRNA stability via 
interaction with its 3’-UTR. Whereas HuR is known 
to bind at multiple locations of the transcript for its 
mRNA targets (Lopez de Silanes et al., 2004), its 
functions in the enhancement of mRNA stability are 
largely driven via interaction with AU-rich elements 
located in 3’-UTRs (Brennan and Steitz, 2001; Leb-
edeva et al., 2011). Consistent with this hypothesis, 
using computational analysis (Cook et al., 2011) we 
identified multiple potential HuR binding sites within 
the Draxin 3’-UTR (Figure 3—Supplement 1). Fur-
ther, our Draxin overexpression construct lacked 
its endogenous 3’-UTR and did not require HuR for 
stable expression (Fig. 4), unlike the endogenous 
mRNA, likely accounting for its ability to rescue.
It is important to note that, while HuR expression 
persists in cranial neural crest during the initiation of 
EMT and migration, Draxin must be rapidly down-
regulated for these processes to proceed (Hutchins 
and Bronner, 2018, 2019). Thus, we hypothesize 
that HuR becomes endogenously displaced from 
Draxin at the onset of EMT. RBPs are known to al-
ter association with targets due to post-translational 
modifications such as phosphorylation or alternative 
RBP competition (Dassi, 2017; Garcia-Maurino et al., 
2017). Indeed, inhibition of serine-threonine kinases 
has been shown in neural crest to increase cell-cell 
adhesions and negatively impact cell migration (Mon-
ier-Gavelle and Duband, 1995), thus suggesting ki-
nase-driven signaling pathway activation coincident 
with neural crest EMT. With established roles for ser-
ine-threonine phosphorylation in modulating HuR’s 
RNA binding activity and target selection (Grammati-
kakis et al., 2017), we speculate that HuR phosphor-
ylation at the onset of EMT may facilitate exchange 
of HuR-bound targets, and promote Draxin release 
and turnover. 
Because its primary target during specification is 
downregulated while HuR expression persists, this 
suggests there are likely additional targets and roles 
for HuR beyond Draxin stabilization. HuR has been 
shown in other contexts to stabilize Snail1 (Dong et 
al., 2007) and matrix metalloprotease-9 (MMP-9) 
(Yuan et al., 2011), factors with well-established roles 
in neural crest EMT (Cano et al., 2000; Kalev-Alt-
man et al., 2020; Monsonego-Ornan et al., 2012; 
Strobl-Mazzulla and Bronner, 2012; Taneyhill et al., 
2007). Given that the neural crest specification GRN 
is proceeded by activation of an EMT GRN also co-
inciding with HuR expression, we speculate that HuR 
may intersect with additional GRNs following specifi-
cation. 
In summary, we identified a critical role for HuR in 
the maintenance of cranial neural crest specification. 
Loss of HuR has deleterious effects on completion 
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7of neural crest specification and delamination due to 
destabilization of its target, Draxin. The continued ex-
pression of HuR during cranial neural crest migration, 
after Draxin has been endogenously downregulated, 
suggests additional that HuR may play additional 
roles at later stages of neural crest development, 
particularly following EMT and during cell migration.
ACKNOWLEDGMENTS
We thank A. Collazo and G. Spigolon for imaging as-
sistance at the Caltech Biological Imaging Facility; M. 
Schwarzkopf and G. Shin (Molecular Technologies) 
for HCR probe design; G. da Silva Pescador and R. 
Galton for assistance with pilot experiments. 
FUNDING
This work was supported by the National Institutes 
of Health [R01DE027538 and R01DE027568 to 
M.E.B; K99DE028592 to E.J.H], the Amgen Founda-
tion Caltech Amgen Scholars Program [J.C.], and the 
California State University—Northridge BUILD POD-
ER program [J.C.].
COMPETING INTERESTS
The authors declare no competing interests.
REFERENCES
Abdelmohsen, K., Gorospe, M., 2010. Posttranscriptional regulation of 
cancer traits by HuR. Wiley Interdiscip Rev RNA 1, 214-229.
Betancur, P., Bronner-Fraser, M., Sauka-Spengler, T., 2010. Genomic 
code for Sox10 activation reveals a key regulatory enhancer for cranial 
neural crest. Proceedings of the National Academy of Sciences of the 
United States of America 107, 3570-3575.
Bhattacharya, D., Rothstein, M., Azambuja, A.P., Simoes-Costa, M., 
2018. Control of neural crest multipotency by Wnt signaling and the 
Lin28/let-7 axis. Elife 7.
Brennan, C.M., Steitz, J.A., 2001. HuR and mRNA stability. Cell Mol Life 
Sci 58, 266-277.
Cano, A., Perez-Moreno, M.A., Rodrigo, I., Locascio, A., Blanco, M.J., 
del Barrio, M.G., Portillo, F., Nieto, M.A., 2000. The transcription factor 
snail controls epithelial-mesenchymal transitions by repressing E-cad-
herin expression. Nature cell biology 2, 76-83.
Chacon, J., Rogers, C.D., 2019. Early expression of Tubulin Beta-III in 
avian cranial neural crest cells. Gene expression patterns : GEP 34, 
119067.
Cook, K.B., Kazan, H., Zuberi, K., Morris, Q., Hughes, T.R., 2011. RB-
PDB: a database of RNA-binding specificities. Nucleic acids research 
39, D301-308.
Dassi, E., 2017. Handshakes and Fights: The Regulatory Interplay of 
RNA-Binding Proteins. Front Mol Biosci 4, 67.
Dong, R., Lu, J.G., Wang, Q., He, X.L., Chu, Y.K., Ma, Q.J., 2007. Sta-
bilization of Snail by HuR in the process of hydrogen peroxide induced 
cell migration. Biochem Biophys Res Commun 356, 318-321.
Faul, F., Erdfelder, E., Lang, A.G., Buchner, A., 2007. G*Power 3: a 
flexible statistical power analysis program for the social, behavioral, and 
biomedical sciences. Behav Res Methods 39, 175-191.
Gandhi, S., Bronner, M.E., 2018. Insights into neural crest development 
from studies of avian embryos. The International journal of developmen-
tal biology 62, 183-194.
Gandhi, S., Hutchins, E.J., Maruszko, K., Park, J.H., Thomson, M., 
Bronner, M.E., 2020. Bimodal function of chromatin remodeler Hmga1 in 
neural crest induction and Wnt-dependent emigration. Elife 9.
Garcia-Maurino, S.M., Rivero-Rodriguez, F., Velazquez-Cruz, A., Her-
nandez-Vellisca, M., Diaz-Quintana, A., De la Rosa, M.A., Diaz-Moreno, 
I., 2017. RNA Binding Protein Regulation and Cross-Talk in the Control 
of AU-rich mRNA Fate. Front Mol Biosci 4, 71.
Grammatikakis, I., Abdelmohsen, K., Gorospe, M., 2017. Posttransla-
tional control of HuR function. Wiley Interdiscip Rev RNA 8.
Hamburger, V., Hamilton, H.L., 1951. A series of normal stages in the 
development of the chick embryo. J Morphol 88, 49-92.
Hutchins, E.J., Bronner, M.E., 2018. Draxin acts as a molecular rheostat 
of canonical Wnt signaling to control cranial neural crest EMT. The 
Journal of cell biology 217, 3683-3697.
Hutchins, E.J., Bronner, M.E., 2019. Draxin alters laminin organization 
during basement membrane remodeling to control cranial neural crest 
EMT. Developmental biology 446, 151-158.
Hutchins, E.J., Szaro, B.G., 2013. c-Jun N-terminal kinase phosphoryla-
tion of heterogeneous nuclear ribonucleoprotein K regulates vertebrate 
axon outgrowth via a posttranscriptional mechanism. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 33, 
14666-14680.
Jayaseelan, S., Doyle, F., Tenenbaum, S.A., 2014. Profiling post-tran-
scriptionally networked mRNA subsets using RIP-Chip and RIP-Seq. 
Methods 67, 13-19.
Kalev-Altman, R., Hanael, E., Zelinger, E., Blum, M., Monsonego-Or-
nan, E., Sela-Donenfeld, D., 2020. Conserved role of matrix metallopro-
teases 2 and 9 in promoting the migration of neural crest cells in avian 
and mammalian embryos. FASEB J 34, 5240-5261.
Katsanou, V., Milatos, S., Yiakouvaki, A., Sgantzis, N., Kotsoni, A., Alex-
iou, M., Harokopos, V., Aidinis, V., Hemberger, M., Kontoyiannis, D.L., 
2009. The RNA-binding protein Elavl1/HuR is essential for placental 
branching morphogenesis and embryonic development. Molecular and 
cellular biology 29, 2762-2776.
Kim, I., Hur, J., Jeong, S., 2015. HuR represses Wnt/beta-catenin-me-
diated transcriptional activity by promoting cytoplasmic localization of 
beta-catenin. Biochem Biophys Res Commun 457, 65-70.
Lebedeva, S., Jens, M., Theil, K., Schwanhausser, B., Selbach, M., 
Landthaler, M., Rajewsky, N., 2011. Transcriptome-wide analysis of 
regulatory interactions of the RNA-binding protein HuR. Mol Cell 43, 
340-352.
Lopez de Silanes, I., Zhan, M., Lal, A., Yang, X., Gorospe, M., 2004. 
Identification of a target RNA motif for RNA-binding protein HuR. Pro-
ceedings of the National Academy of Sciences of the United States of 
America 101, 2987-2992.
Ma, W.J., Cheng, S., Campbell, C., Wright, A., Furneaux, H., 1996. 
Cloning and characterization of HuR, a ubiquitously expressed Elav-like 
protein. The Journal of biological chemistry 271, 8144-8151.
Manohar, S., Camacho, A., Rogers, C.D., 2020. Cadherin-11 
is required for neural crest determination and survival. bioRxiv, 
2020.2005.2018.066613.
Martik, M.L., Bronner, M.E., 2017. Regulatory Logic Underlying Diversifi-
cation of the Neural Crest. Trends Genet.
Megason, S.G., McMahon, A.P., 2002. A mitogen gradient of dorsal mid-
line Wnts organizes growth in the CNS. Development 129, 2087-2098.
Milet, C., Monsoro-Burq, A.H., 2012. Neural crest induction at the neural 
plate border in vertebrates. Developmental biology 366, 22-33.
Monier-Gavelle, F., Duband, J.L., 1995. Control of N-cadherin-mediated 
intercellular adhesion in migrating neural crest cells in vitro. J Cell Sci 
108 ( Pt 12), 3839-3853.
Monsonego-Ornan, E., Kosonovsky, J., Bar, A., Roth, L., Fraggi-Rankis, 
.CC-BY-NC 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted October 14, 2020. . https://doi.org/10.1101/2020.10.14.338715doi: bioRxiv preprint 
8V., Simsa, S., Kohl, A., Sela-Donenfeld, D., 2012. Matrix metalloprotein-
ase 9/gelatinase B is required for neural crest cell migration. Develop-
mental biology 364, 162-177.
Palomo-Irigoyen, M., Perez-Andres, E., Iruarrizaga-Lejarreta, M., Barrei-
ra-Manrique, A., Tamayo-Caro, M., Vila-Vecilla, L., Moreno-Cugnon, L., 
Beitia, N., Medrano, D., Fernandez-Ramos, D., Lozano, J.J., Okawa, S., 
Lavin, J.L., Martin-Martin, N., Sutherland, J.D., de Juan, V.G., Gon-
zalez-Lopez, M., Macias-Camara, N., Mosen-Ansorena, D., Laraba, 
L., Hanemann, C.O., Ercolano, E., Parkinson, D.B., Schultz, C.W., 
Arauzo-Bravo, M.J., Ascension, A.M., Gerovska, D., Iribar, H., Izeta, 
A., Pytel, P., Krastel, P., Provenzani, A., Seneci, P., Carrasco, R.D., 
Del Sol, A., Martinez-Chantar, M.L., Barrio, R., Serra, E., Lazaro, C., 
Flanagan, A.M., Gorospe, M., Ratner, N., Aransay, A.M., Carracedo, 
A., Varela-Rey, M., Woodhoo, A., 2020. HuR/ELAVL1 drives malignant 
peripheral nerve sheath tumor growth and metastasis. J Clin Invest 130, 
3848-3864.
Rabadán, M.A., Herrera, A., Fanlo, L., Usieto, S., Carmona-Fontaine, 
C., Barriga, E.H., Mayor, R., Pons, S., Marti, E., 2016. Delamination of 
neural crest cells requires transient and reversible Wnt inhibition mediat-
ed by Dact1/2. Development 143, 2194-2205.
Sanchez-Vasquez, E., Bronner, M.E., Strobl-Mazzulla, P.H., 2019. 
Epigenetic inactivation of miR-203 as a key step in neural crest epitheli-
al-to-mesenchymal transition. Development 146.
Simoes-Costa, M., Bronner, M.E., 2015. Establishing neural crest identi-
ty: a gene regulatory recipe. Development 142, 242-257.
Simoes-Costa, M., Stone, M., Bronner, M.E., 2015. Axud1 Integrates 
Wnt Signaling and Transcriptional Inputs to Drive Neural Crest Forma-
tion. Developmental cell 34, 544-554.
Steventon, B., Mayor, R., 2012. Early neural crest induction requires an 
initial inhibition of Wnt signals. Developmental biology 365, 196-207.
Strobl-Mazzulla, P.H., Bronner, M.E., 2012. A PHD12-Snail2 repressive 
complex epigenetically mediates neural crest epithelial-to-mesenchymal 
transition. The Journal of cell biology 198, 999-1010.
Taneyhill, L.A., Coles, E.G., Bronner-Fraser, M., 2007. Snail2 directly 
represses cadherin6B during epithelial-to-mesenchymal transitions of 
the neural crest. Development 134, 1481-1490.
van Limborgh, J., Lieuw Kie Song, S.H., Been, W., 1983. Cleft lip and 
palate due to deficiency of mesencephalic neural crest cells. Cleft 
Palate J 20, 251-259.
Vega-Lopez, G.A., Cerrizuela, S., Tribulo, C., Aybar, M.J., 2018. Neuro-
cristopathies: New insights 150 years after the neural crest discovery. 
Developmental biology.
Wang, J., Guo, Y., Chu, H., Guan, Y., Bi, J., Wang, B., 2013. Multiple 
functions of the RNA-binding protein HuR in cancer progression, treat-
ment responses and prognosis. Int J Mol Sci 14, 10015-10041.
Ward, N.J., Green, D., Higgins, J., Dalmay, T., Munsterberg, A., Moxon, 
S., Wheeler, G.N., 2018. microRNAs associated with early neural crest 
development in Xenopus laevis. BMC Genomics 19, 59.
Weiner, A.M.J., 2018. MicroRNAs and the neural crest: From induction 
to differentiation. Mechanisms of development 154, 98-106.
Williams, R.M., Candido-Ferreira, I., Repapi, E., Gavriouchkina, D., 
Senanayake, U., Ling, I.T.C., Telenius, J., Taylor, S., Hughes, J., Sau-
ka-Spengler, T., 2019. Reconstruction of the Global Neural Crest Gene 
Regulatory Network In Vivo. Developmental cell 51, 255-276 e257.
Wu, J., Saint-Jeannet, J.P., Klein, P.S., 2003. Wnt-frizzled signaling in 
neural crest formation. Trends Neurosci 26, 40-45.
Yanfeng, W., Saint-Jeannet, J.P., Klein, P.S., 2003. Wnt-frizzled signal-
ing in the induction and differentiation of the neural crest. Bioessays 25, 
317-325.
Yao, K.M., Samson, M.L., Reeves, R., White, K., 1993. Gene elav of 
Drosophila melanogaster: a prototype for neuronal-specific RNA binding 
protein gene family that is conserved in flies and humans. Journal of 
neurobiology 24, 723-739.
Yuan, Z., Sanders, A.J., Ye, L., Wang, Y., Jiang, W.G., 2011. Knockdown 
of human antigen R reduces the growth and invasion of breast cancer 
cells in vitro and affects expression of cyclin D1 and MMP-9. Oncol Rep 
26, 237-245.
Zuker, M., 2003. Mfold web server for nucleic acid folding and hybridiza-
tion prediction. Nucleic acids research 31, 3406-3415.
METHODS
Model organism and embryo collection
Fertile chicken eggs (Gallus gallus) were pur-
chased locally (Sunstate Ranch, Sylmar, CA), and 
incubated in a humidified 37ºC incubator to the spec-
ified Hamburger-Hamilton (HH) stage (Hamburger 
and Hamilton, 1951). Live embryos were removed 
from eggs with Whatman filter paper as described 
(Hutchins and Bronner, 2018, 2019) and stored in 
Ringer’s solution until further processing.
Immunohistochemistry and Hybridization 
Chain Reaction
For whole mount immunohistochemistry, embry-
os were fixed at room temperature for 20 min with 
4% paraformaldehyde in sodium phosphate buffer. 
For cross-sections, embryos were fixed at room 
temperature for 1 h, then washed, embedded, and 
cryosectioned as described (Hutchins and Bronner, 
2018, 2019) prior to immunohistochemistry. Washes, 
blocking (10% donkey serum), and antibody incuba-
tions were performed in TBSTx (0.5 M Tris-HCl/1.5 
M NaCl/10 mM CaCl2/0.5% Triton X-100/0.001% Thi-
merosal) as described (Chacon and Rogers, 2019; 
Manohar et al., 2020). Primary antibodies are listed 
in the Key Resources Table. Species-specific sec-
ondary antibodies were labeled with Alexa Fluor 568 
and 647 (Invitrogen) and used at 1:1000 or 1:500, 
respectively. For nuclear staining on cross-sections, 
DAPI (4’,6-Diamidino-2-Phenylindole) was added to 
the secondary antibody solution at [14.3 μM] final 
concentration. Coverslips were mounted using Fluo-
romount-G (SouthernBiotech).
Hybridization Chain Reaction (HCR) was per-
formed as described (Gandhi et al., 2020). Embryos 
were fixed at room temperature for 1 h with 4% para-
formaldehyde in phosphate buffered saline (PBS) pri-
or to HCR processing. Custom HCR probes were de-
signed and ordered through Molecular Technologies.
Gene expression constructs and 
perturbation
Translation-blocking antisense morpholino oligo 
for HuR (Gene Tools; Key Resources Table) was de-
signed to span the Elavl1 (NCBI NM_204833.1) start 
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9codon from nucleotide −20 to +5 (HuR MO), and 
electroporated at [2 mM]. Draxin MO was described 
previously (Hutchins and Bronner, 2018, 2019), and 
electroporated at [1 mM]. The standard control MO 
(Gene Tools) was used for contralateral control elec-
troporation. MOs were co-electroporated with pCIG 
(Megason and McMahon, 2002) or pCI-H2B-RFP 
(Betancur et al., 2010) to increase electroporation 
efficiency and to visualize successfully electroporat-
ed cells. The Draxin-FLAG construct to drive overex-
pression (Draxin OE) and the GFP-tagged stabilized 
β-catenin (NC1-Δ90βcat) construct were described 
previously (Hutchins and Bronner, 2018, 2019). Elec-
troporations were performed on HH4 gastrula stage 
chicken embryos as described previously (Hutchins 
and Bronner, 2018, 2019).
RNA immunoprecipitation (RIP) and qRT-PCR
RNA immunoprecipitation (RIP) was performed 
as described (Hutchins and Szaro, 2013; Jayaseelan 
et al., 2014), with minor modifications. Briefly, Pro-
tein-G Dynabeads were washed with NT-2 (50 mM 
Tris-HCl, 150 mM NaCl, 1 mM MgCl2, 0.05% NP-40), 
blocked in NT-2/5% BSA for 1 h at room temperature, 
then incubated with 5 μg antibody (HuR IgG or Con-
trol IgG) in NT-2/5% BSA for 1 h at room tempera-
ture. Following antibody incubation, antibody-coated 
beads were washed with NT-2 and resuspended in 
NET-2 (NT-2, 20 mM EDTA, 400 U RNaseOUT, 1x 
cOmplete, Mini EDTA-free Protease Inhibitor) until 
addition of cleared lysate.
Embryonic heads were dissected in Ringer’s 
solution, washed in RNase-free PBS, and disso-
ciated in Accumax (Innovative Cell Technologies) 
for 15 min at room temperature. Following dissoci-
ation, cells were pelleted at 2000 x g for 4 min at 
4ºC, washed in RNase-free PBS, and resuspended 
in Polysome Lysis Buffer (0.1 M KCl, 5 mM MgCl2, 
10 mM HEPES, 0.5% NP-40, 200 U RNaseOUT, 1x 
cOmplete, Mini EDTA-free Protease Inhibitor). Cells 
were frozen at −80ºC overnight to complete lysis and 
reduce adventitious binding. Lysate was then thawed 
on ice, vortexed, and centrifuged at 14,000 x g for 10 
min at 4ºC to remove cellular debris, then cleared ly-
sate was added to antibody-coated beads in NET-2. 
Immediately following addition of cleared lysate, 10% 
was removed to serve as an Input control. IP reac-
tion was tumbled at room temperature for 1 h, beads 
were then washed in NT-2, and RNA was eluted in 
Proteinase K Buffer (NT-2, 1% SDS, 1.2 mg/mL Pro-
teinase K) for 30 min at 55ºC and phenol/chloroform 
extracted.
RNA from Input and IP samples was reverse 
transcribed using SuperScript III and oligo dT prim-
ing. Following reverse transcription, we performed 
qPCR using FastStart Universal SYBR Green Mas-
ter (Rox) with cDNA (diluted 1:5) and gene-specific 
primers (Key Resources Table) on a QuantStudio 3 
Real-Time PCR System (Applied Biosystems) in trip-
licate. We determined ΔCT (ΔCT = Input CT − IP CT) 
for Draxin, FoxD3, and Pax7 for HuR and Control IgG 
RIP samples, then calculated ΔΔCT values (ΔΔCT = 
Average Control IgG ΔCT − HuR ΔCT) for each target 
and replicate.
Image acquisition and analysis
Confocal images were acquired using an upright 
Zeiss LSM 880 at the Caltech Biological Imaging 
Facility, and epifluorescence images were acquired 
using a Zeiss Imager.M2 with an ApoTome.2 mod-
ule. Images were minimally processed for brightness/
contrast and pseudocolored using Fiji (ImageJ, NIH) 
and Adobe Photoshop 2020.
Relative fluorescence intensity was determined 
in Fiji. For each whole mount image, the line tool was 
used to draw an ROI surrounding the area of neu-
ral crest indicated by positive HCR fluorescence for 
the genes examined. For cross-sections, ROIs were 
drawn surrounding the neural crest and neural tube 
based on tissue morphology from nuclear staining. 
Following background subtraction (50-pixel rolling 
ball radius), integrated density was quantified for the 
ROIs on the control electroporated (left) and exper-
imental electroporated (right) sides from the same 
embryo. Relative fluorescence intensity was then cal-
culated by dividing the integrated density measure-
ments for the experimental versus the control side of 
the same embryo.
Pax7 cell counts were performed as described 
(Hutchins and Bronner, 2018). The limit of the dorsal 
neural tube and characterization of cells as “delam-
inated” or “neural tube” was determined based on 
tissue morphology from nuclear staining. For relative 
migration distance determined from Pax7-stained 
embryos, distance of migration was measured in Fiji 
as described (Hutchins and Bronner, 2018).
RNA structure and HuR binding site prediction
Secondary structure for the Draxin 3’-UTR (Gen-
Bank: AB427147.1) was predicted using ‘mfold’ web 
server (Zuker, 2003). HuR binding sites were predict-
ed using RBPDB (Cook et al., 2011).
Statistical analyses
Statistical analyses were performed using Prism 
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(8; GraphPad Software). P values are defined in the 
text, and significance was established with P < 0.05. 
P values were calculated using paired t-tests, one-
way ANOVA with post hoc Tukey, or unpaired t-tests 
as indicated in the text; tests were two-tailed unless 
otherwise specified in the text/legend. Data mea-
suring fluorescence intensities or cell counts for Ex-
perimental/Control sides are presented as box plots 
with individual data points shown. Bar graphs repre-
senting qPCR ΔΔCT are presented as mean values, 
with error bars indicating SEM. Number of embryos 
and replicates are indicated in figure legends and/or 
text. Data were assumed to be normally distributed 
but were not formally tested. Post hoc power analy-
ses (Faul et al., 2007) confirmed sufficient statistical 
power was reached (≥0.8) for reported P values and 
sample sizes.
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KEY RESOURCES TABLE 
Reagent or resource Source Identifier 
Antibodies 




HuR/Elavl1; Species: Rabbit Abcam Cat# ab196626 
IgG, polyclonal - Isotype Control (ChIP Grade); Species: 
Rabbit 
Abcam Cat# ab171870 
Chemicals, Peptides, and Recombinant Proteins 
Fluoromount-G SouthernBiotech Cat# 0100-01 
DAPI Thermo Fisher Cat# D1306  
FastStart Universal SYBR Green Master (Rox) Millipore/Sigma Cat# 
FSUSGMMRO 
SuperScript III Reverse Transcriptase Thermo Fisher Cat# 18080044 
cOmplete, Mini, EDTA-free Protease Inhibitor Millipore/Sigma Cat# 
11836170001 
RNaseOUT Recombinant Ribonuclease Inhibitor Thermo Fisher Cat# 10777019 
Accumax Innovative Cell 
Technologies, Inc 
Cat# AM105 
Protein G Dynabeads Thermo Fisher Cat# 10003D 
Experimental Models: Organisms/Strains 
Gallus gallus Sun State Ranch 
(Monrovia, CA, USA) 
N/A 
Oligonucleotides 






Hutchins and Bronner, 
2018; GeneTools 
N/A 
Draxin qPCR F Primer: CTACGCTGTTATGCCAAATTCC This paper; IDT N/A 
Draxin qPCR R Primer: GAATGATCCCTGCTCTCCATT This paper; IDT N/A 
FoxD3 qPCR F Primer: CATCTGCGAGTTCATCAGCA This paper; IDT N/A 
FoxD3 qPCR R Primer: TTCACGAAGCAGTCGTTGAG This paper; IDT N/A 
Pax7 qPCR F Primer: CAAACCAACTCGCAGCATTC This paper; IDT N/A 
Pax7 qPCR R Primer: CTGCCTCCATCTTGGGAAAT This paper; IDT N/A 
Recombinant DNA 
pCI-H2B-RFP Betancur et al., 2010 N/A 
pCIG Megason and 
McMahon, 2002 
N/A 
Draxin-FLAG Hutchins and Bronner, 
2018 
N/A 
Software and Algorithms 
Prism8 GraphPad N/A 
ImageJ64 NIH N/A 
Fiji Schindelin et al., 2012 N/A 
QuantStudio Design & Analysis software, version 2.4 Life Technologies N/A 
Zen 2 Blue Zeiss N/A 
Zen Black Zeiss N/A 
Photoshop CC Adobe N/A 
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Figure 2—Supplement 1. Translation-blocking morpholino suppresses HuR expression.
(A) Representative confocal maximum intensity projection micrograph of cross-sectioned embryo bilaterally co-electroporated with a 
fluorescent electroporation control construct (H2B-RFP) and control morpholino (left) or HuR morpholino (right), immunostained for HuR 
(cyan). Dotted white line indicates midline. Scale bar, 20 μm.
(B) Relative fluorescence intensity of HuR for HuR knockdown compared to control sides of cross-sections, calculated as ratio of HuR 
morpholino versus control morpholino integrated density. Data are from individual sections; sections from same embryo are displayed in same 
color (n = 5 embryos, 15 sections) *, P < 0.001, paired t-test.
.CC-BY-NC 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted October 14, 2020. . https://doi.org/10.1101/2020.10.14.338715doi: bioRxiv preprint 
13
Figure 3—Supplement 1. Predicted HuR binding sites within the Draxin 3’-UTR.
A representative secondary structure of the Draxin 3’-UTR, predicted by ‘mfold’ analysis. Predicted HuR binding sites are highlighted 
in blue.
.CC-BY-NC 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted October 14, 2020. . https://doi.org/10.1101/2020.10.14.338715doi: bioRxiv preprint 
14
Figure 4—Supplement 1. HuR knockdown inhibits cranial neural crest EMT.
(A) Representative confocal maximum intensity projection micrograph of whole mount embryo bilaterally co-electroporated with a fluorescent 
electroporation control construct (H2B-RFP) and control morpholino (left) or HuR morpholino (right), immunostained for Pax7 (yellow). Dotted 
white line indicates midline. MO, morpholino. Scale bar, 50 μm.
(B) Relative migration distance for electroporated sides compared to control sides of whole mount embryos, calculated as ratio. Data are from 
individual embryos (n = 5 embryos, 5 measurements per embryo averaged). *, P < 0.001, paired t-test).
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